Table 6 Distribution of the status of complete pathological response by the BC subtypes among the studied breast cancer patients
From: Neoadjuvant chemotherapy for stage II–III breast cancer: a single-center experience
Yes | No | p value | ||||
|---|---|---|---|---|---|---|
Count | Row N % | Count | Row N % | |||
BC subtypes | Luminal A | 6 | 28.6% | 15 | 71.4% | < 0.001* |
Luminal B | 18 | 46.2% | 21 | 53.8% | ||
HER 2 +ve | 41 | 77.4% | 12 | 22.6% | ||
Triple-negative | 21 | 61.8% | 13 | 38.2% | ||
Total | 86 | 58.5% | 61 | 41.5% | ||